» Articles » PMID: 24726420

Bronchiectases at Early Chest Computed Tomography in Children with Cystic Fibrosis Are Associated with Increased Risk of Subsequent Pulmonary Exacerbations and Chronic Pseudomonas Infection

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2014 Apr 15
PMID 24726420
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Children with cystic fibrosis (CF) are often Pseudomonas aeruginosa (PsA) free and exhibit normal spirometry between the ages of 5 and 7. It is reported that computed tomography (CT) is more sensitive than FEV1 as an instrument in the identification of pulmonary disease. It is not known whether CF-CT scores in childhood may be used to highlight children at risk of developing severe disease.

Aims: 1 - To assess the number of respiratory exacerbations (RTEs) during a follow-up period of 6 years and their correlation with the CF-CT scores in young CF children. 2 - To assess whether PsA-negative CF children with high chest CF-CT scores are more likely to develop chronic PsA lung infection.

Methods: 68 chest CT performed in patients without chronic PsA infection were scored. All patients (median age 7.8 years) had at least 4 clinical, functional and microbiologic assessments/year in the subsequent 6 years. RTE was defined as hospitalization and IV antibiotic treatment for respiratory symptoms.

Results: 86.8% patients had <3 RTEs in the 6 year follow-up period. The number of RTEs in the 6 years subsequent to the CT scan was correlated to the bronchiectasis CT score (BCTS) (r = 0.612; p < 0.001) and to FEV1 at baseline (r = -0.495, p<0.001). A BCTS ≥ 17.5 identified patients with >3 RTEs during follow-up (sensitivity: 100%, specificity: 85%), while FEV1 did not. Only BCTS was significant in a logistic multivariate model (RR 1.15). BCTS was significantly lower and FEV1 higher in patients who did not develop chronic PsA infection by the end of the study.

Conclusion: In CF children free from chronic PsA, both CT scores and FEV1 values demonstrate significant correlation with disease severity in the subsequent 6 years but CT score has higher predictive value in the identification of patients at risk.

Citing Articles

Substrate-dependent metabolomic signatures of myeloperoxidase activity in airway epithelial cells: Implications for early cystic fibrosis lung disease.

Kim S, Shapiro J, Cottrill K, Collins G, Shanthikumar S, Rao P Free Radic Biol Med. 2023; 206:180-190.

PMID: 37356776 PMC: 10513041. DOI: 10.1016/j.freeradbiomed.2023.06.021.


State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium.

Ciet P, Bertolo S, Ros M, Casciaro R, Cipolli M, Colagrande S Eur Respir Rev. 2022; 31(163).

PMID: 35321929 PMC: 9489084. DOI: 10.1183/16000617.0173-2021.


QUANTIFICATION OF PULMONARY PATHOLOGY IN CYSTIC FIBROSIS-COMPARISON BETWEEN DIGITAL CHEST TOMOSYNTHESIS AND COMPUTED TOMOGRAPHY.

Meltzer C, Gilljam M, Vikgren J, Norrlund R, Vult von Steyern K, Bath M Radiat Prot Dosimetry. 2021; 195(3-4):434-442.

PMID: 33683309 PMC: 8507459. DOI: 10.1093/rpd/ncab017.


Airway tapering: an objective image biomarker for bronchiectasis.

Kuo W, Perez-Rovira A, Tiddens H, De Bruijne M Eur Radiol. 2020; 30(5):2703-2711.

PMID: 32025831 PMC: 7160094. DOI: 10.1007/s00330-019-06606-w.


Airway disease on chest computed tomography of preschool children with cystic fibrosis is associated with school-age bronchiectasis.

Bouma N, Janssens H, Andrinopoulou E, Tiddens H Pediatr Pulmonol. 2019; 55(1):141-148.

PMID: 31496137 PMC: 6972540. DOI: 10.1002/ppul.24498.